Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L M Itri

Showing results (31-40 of 45) with videos related to

Pageof 5
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|September 14, 2000
Erythropoietin crosses the blood-brain barrier to protect against experimental brain injuryM L Brines, P Ghezzi, S Keenan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1984
Phase II study of low-dose recombinant leukocyte A interferon in disseminated malignant melanomaE T Creagan, D L Ahmann, S J Green, et al.
The New England Journal of Medicine|June 2, 1988
Resistance to recombinant interferon alfa-2a in hairy-cell leukemia associated with neutralizing anti-interferon antibodiesR G Steis, J W Smith, W J Urba, et al.
The New England Journal of Medicine|December 11, 1986
13-cis-retinoic acid in the treatment of oral leukoplakiaW K Hong, J Endicott, L M Itri, et al.
The New England Journal of Medicine|May 26, 1991
Differentiation therapy of acute promyelocytic leukemia with tretinoin (all-trans-retinoic acid)R P Warrell, S R Frankel, W H Miller, et al.
Cancer|March 15, 1983
Cisplatin, vindesine and bleomycin (CVB) combination chemotherapy of advanced non-small cell lung cancerL M Itri, R J Gralla, D P Kelsen, et al.
Blood|February 15, 1991
Loss of interferon antibodies during prolonged continuous interferon-alpha 2a therapy in hairy cell leukemiaR G Steis, J W Smith, W J Urba, et al.
Investigational New Drugs|April 1, 1988
Treatment of advanced squamous cell carcinoma of the head and neck with isotretinoin: a phase II randomized trialS M Lippman, J F Kessler, M Al-Sarraf, et al.
The New England Journal of Medicine|October 15, 1981
Antiemetic efficacy of high-dose metoclopramide: randomized trials with placebo and prochlorperazine in patients with chemotherapy-induced nausea and vomitingR J Gralla, L M Itri, S E Pisko, et al.
Seminars in Hematology|July 1, 1997
Patient, caregiver, and oncologist perceptions of cancer-related fatigue: results of a tripart assessment survey. The Fatigue CoalitionN J Vogelzang, W Breitbart, D Cella, et al.
Pageof 5

Showing results (31-40 of 45) with videos related to

Sort By:
Pageof 5
Proceedings of the National Academy of Sciences of the United States of America|September 14, 2000
Erythropoietin crosses the blood-brain barrier to protect against experimental brain injuryM L Brines, P Ghezzi, S Keenan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1984
Phase II study of low-dose recombinant leukocyte A interferon in disseminated malignant melanomaE T Creagan, D L Ahmann, S J Green, et al.
The New England Journal of Medicine|June 2, 1988
Resistance to recombinant interferon alfa-2a in hairy-cell leukemia associated with neutralizing anti-interferon antibodiesR G Steis, J W Smith, W J Urba, et al.
The New England Journal of Medicine|December 11, 1986
13-cis-retinoic acid in the treatment of oral leukoplakiaW K Hong, J Endicott, L M Itri, et al.
The New England Journal of Medicine|May 26, 1991
Differentiation therapy of acute promyelocytic leukemia with tretinoin (all-trans-retinoic acid)R P Warrell, S R Frankel, W H Miller, et al.
Cancer|March 15, 1983
Cisplatin, vindesine and bleomycin (CVB) combination chemotherapy of advanced non-small cell lung cancerL M Itri, R J Gralla, D P Kelsen, et al.
Blood|February 15, 1991
Loss of interferon antibodies during prolonged continuous interferon-alpha 2a therapy in hairy cell leukemiaR G Steis, J W Smith, W J Urba, et al.
Investigational New Drugs|April 1, 1988
Treatment of advanced squamous cell carcinoma of the head and neck with isotretinoin: a phase II randomized trialS M Lippman, J F Kessler, M Al-Sarraf, et al.
The New England Journal of Medicine|October 15, 1981
Antiemetic efficacy of high-dose metoclopramide: randomized trials with placebo and prochlorperazine in patients with chemotherapy-induced nausea and vomitingR J Gralla, L M Itri, S E Pisko, et al.
Seminars in Hematology|July 1, 1997
Patient, caregiver, and oncologist perceptions of cancer-related fatigue: results of a tripart assessment survey. The Fatigue CoalitionN J Vogelzang, W Breitbart, D Cella, et al.
Pageof 5